Proscia

Proscia

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.proscia.com

Last Round

Series C

Mar 19, 2025

Total Funding Raised

$137.3M

Company Overview

Proscia is a digital pathology company that offers a platform designed to improve cancer diagnosis by utilizing advanced computing technologies to reveal hidden data and transform it into actionable insights for better patient outcomes and accelerated medical advancements.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Precision Medicine, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

digital pathologypathology AIpathology platformcomputational pathologywhole slide imagingpathology softwarereal-world dataRWDcancer diagnosisFDA-cleared AIpathology workflowdrug discoverypathology dataAI developer toolkitpathology embeddingsgovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proscia Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Proscia Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CMar 19, 2025
Series C ExtensionMar 14, 2024
Series CDec 29, 2023
Series CJun 14, 2022
Series BDec 1, 2020
Series A
Sep 26, 2018

Key People

Founding team and executive leadership

Coleman Stavish

Co-founder CTO

Founding Team

Nathan Buchbinder

Co-Founder Chief Strategy Officer

Founding Team

David West

Co-Founder, CEO

Founding Team

D W

Chief Operating Officer

Executive Team

Proscia Investors

Notable investors and investment history

InvestorRounds
avenuealtd.comSeries C
FlybridgeSeries A
TCP Venture CapitalSeed
Emerald Development ManagersSeries C, Series A, Seed
Fusion FundSeries C, Series A
Triangle Peak PartnersSeries C, Series C Extension
A-Level CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Named "Best in KLAS for Digital Pathology in Europe" and top performer in the U.S.

  • Sep 29, 2025

    Added foodflou, a food technology startup, as a customer.

Proscia Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Proscia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Proscia's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range129
Year Founded2014
Last FundingMar 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.